Rational dosing of gabapentin and pregabalin in chronic kidney disease

被引：33
作者：
Raouf, Mena [1 ]
Atkinson, Timothy J. [1 ]
Crumb, Meredith W. [1 ]
Fudin, Jeffrey [2 ,3 ,4 ,5 ]
机构：
[1] VA Tennessee Valley Healthcare Syst, 3400 Lebanon Pike, Murfreesboro, TN 37129 USA
[2] Stratton VA Med Ctr, Albany, NY USA
[3] Albany Coll Pharm & Hlth Sci, Albany, NY USA
[4] Western New England Univ, Coll Pharm, Springfield, MA USA
[5] Remitigate LLC, Sci & Clin Affairs, Delmar, NY USA
来源：
JOURNAL OF PAIN RESEARCH | 2017年 / 10卷
关键词：
DOUBLE-BLIND; DIABETIC-NEUROPATHY; PHARMACOKINETICS; PAIN; PHARMACODYNAMICS; TRAFFICKING;
D O I：
10.2147/JPR.S130942
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：275 / 278
页数：4
相关论文
共 50 条
  • [41] Ultra-Low Doses of Naltrexone Enhance the Antiallodynic Effect of Pregabalin or Gabapentin in Neuropathic Rats
    Pineda-Farias, Jorge B.
    Caram-Salas, Nadia L.
    Salinas-Abarca, Ana B.
    Ocampo, Jorge
    Granados-Soto, Vinicio
    DRUG DEVELOPMENT RESEARCH, 2017, 78 (08) : 371 - 380
  • [42] Anticoagulation Therapy in Patients with Chronic Kidney Disease
    Sharif-Askari, Fatemeh Saheb
    Sulaiman, Syed Azhar Syed
    Sharif-Askari, Narjes Saheb
    THROMBOSIS AND EMBOLISM: FROM RESEARCH TO CLINICAL PRACTICE, VOL 1, 2017, 906 : 101 - 114
  • [43] Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy
    Colbert, Gates B.
    Madariaga, Hector M.
    Gaddy, Anna
    Elrggal, Mohamed E.
    Lerma, Edgar, V
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 133 - 142
  • [44] Rational Opioid Dosing in the Elderly: Dose and Dosing Interval When Initiating Opioid Therapy
    Gupta, D. K.
    Avram, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (02) : 339 - 343
  • [45] Treatment of Pregabalin Toxicity by Hemodialysis in a Patient With Kidney Failure
    Yoo, Lawrence
    Matalon, Daniel
    Hoffman, Robert S.
    Goldfarb, David S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (06) : 1127 - 1130
  • [46] 'Protective premedication': an option with gabapentin and related drugs? A review of gabapentin and pregabalin in the treatment of post-operative pain
    Dahl, JB
    Mathiesen, O
    Moiniche, S
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2004, 48 (09) : 1130 - 1136
  • [47] Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures
    Bockbrader, Howard N.
    Burger, Paula
    Knapp, Lloyd
    Corrigan, Brian W.
    EPILEPSIA, 2011, 52 (02) : 248 - 257
  • [48] Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients
    Ishida, Julie H.
    McCulloch, Charles E.
    Steinman, Michael A.
    Grimes, Barbara A.
    Johansen, Kirsten L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (07): : 1970 - 1978
  • [49] Preparative Regimen Dosing for Hematopoietic Stem Cell Transplantation in Patients with Chronic Kidney Disease: Analysis of the Literature and Recommendations
    Bodge, Megan N.
    Reddy, Srividya
    Thompson, Michael Scott
    Savani, Bipin N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (07) : 908 - 919
  • [50] Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use
    Calandre, Elena P.
    Rico-Villademoros, Fernando
    Slim, Mahmoud
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (11) : 1263 - 1277
12345